HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McCluggage, W G Search for Related Content PubMed PubMed Citation Articles by McCluggage, W G Pubmed/NCBI databases Medline Plus Health Information Ovarian Cancer

Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms

¹ Department of Pathology, Royal Group of Hospitals Trust, Grosvenor Road, Belfast BT12 6BA, UK

Dr McCluggage This leader reviews recent advances in immunohistochemistry that are useful in the diagnosis of ovarian neoplasms. These include the value of different anticytokeratin antibodies in the distinction between a primary ovarian adenocarcinoma and a metastatic adenocarcinoma, especially of colorectal origin. These antibodies have also helped to clarify the origin of the peritoneal disease in most cases of pseudomyxoma peritonei. The value of antibodies against so called tumour specific antigens, such as CA125 and HAM56, in determining the ovarian origin of an adenocarcinoma is also reviewed. In recent years, several studies have investigated the value of a variety of monoclonal antibodies in the diagnosis of ovarian sex cord stromal tumours and in the distinction between these neoplasms and their histological mimics. These antibodies include those directed against inhibin, CD99, Mullerian inhibiting substance, relaxin like factor, melan A, and calretinin. Of these, anti- inhibin appears to be of most diagnostic value. It is stressed that these antibodies should always be used as part of a larger panel and not in isolation.J Clin Pathol(J Clin Pathol 2000;53:327–334)

Key Words: ovarian neoplasms • diagnosis • immunohistochemistry

This article has been cited by other articles:

				S. Zhang, C. Balch, M. W. Chan, H.-C. Lai, D. Matei, J. M. Schilder, P. S. Yan, T. H-M. Huang, and K. P. Nephew Identification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors Cancer Res., June 1, 2008; 68(11): 4311 - 4320. [Abstract] [Full Text] [PDF]

				E. Riccardi, V. Greco, S. Verganti, and M. Finazzi Immunohistochemical diagnosis of canine ovarian epithelial and granulosa cell tumors J Vet Diagn Invest, July 1, 2007; 19(4): 431 - 435. [Abstract] [Full Text] [PDF]

				V I Shah, O N Freites, P Maxwell, and W G McCluggage Inhibin is more specific than calretinin as an immunohistochemical marker for differentiating sarcomatoid granulosa cell tumour of the ovary from other spindle cell neoplasms J. Clin. Pathol., March 1, 2003; 56(3): 221 - 224. [Abstract] [Full Text] [PDF]

				P J van Diest, H Holzel, M Reid, M Crook, and G Spickett Electronic publishing and internet learning J. Clin. Pathol., December 1, 2002; 55(12): 881 - 882. [Full Text] [PDF]

				W G McCluggage, R W Lyness, R J Atkinson, S P Dobbs, I Harley, H R McClelland, and J H Price Morphological effects of chemotherapy on ovarian carcinoma J. Clin. Pathol., January 1, 2002; 55(1): 27 - 31. [Abstract] [Full Text] [PDF]